268 related articles for article (PubMed ID: 11877379)
1. Stability of a PKCI-1-related mRNA is controlled by the splicing factor ASF/SF2: a novel function for SR proteins.
Lemaire R; Prasad J; Kashima T; Gustafson J; Manley JL; Lafyatis R
Genes Dev; 2002 Mar; 16(5):594-607. PubMed ID: 11877379
[TBL] [Abstract][Full Text] [Related]
2. Novel exploitation of a nuclear function by influenza virus: the cellular SF2/ASF splicing factor controls the amount of the essential viral M2 ion channel protein in infected cells.
Shih SR; Krug RM
EMBO J; 1996 Oct; 15(19):5415-27. PubMed ID: 8895585
[TBL] [Abstract][Full Text] [Related]
3. Targeted disruption of an essential vertebrate gene: ASF/SF2 is required for cell viability.
Wang J; Takagaki Y; Manley JL
Genes Dev; 1996 Oct; 10(20):2588-99. PubMed ID: 8895660
[TBL] [Abstract][Full Text] [Related]
4. Genetic analysis of the SR protein ASF/SF2: interchangeability of RS domains and negative control of splicing.
Wang J; Xiao SH; Manley JL
Genes Dev; 1998 Jul; 12(14):2222-33. PubMed ID: 9679066
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of the SR proteins ASF/SF2 and SC35 influences alternative splicing in vivo in diverse ways.
Wang J; Manley JL
RNA; 1995 May; 1(3):335-46. PubMed ID: 7489505
[TBL] [Abstract][Full Text] [Related]
6. Specific inhibition of serine- and arginine-rich splicing factors phosphorylation, spliceosome assembly, and splicing by the antitumor drug NB-506.
Pilch B; Allemand E; Facompré M; Bailly C; Riou JF; Soret J; Tazi J
Cancer Res; 2001 Sep; 61(18):6876-84. PubMed ID: 11559564
[TBL] [Abstract][Full Text] [Related]
7. The splicing factor-associated protein, p32, regulates RNA splicing by inhibiting ASF/SF2 RNA binding and phosphorylation.
Petersen-Mahrt SK; Estmer C; Ohrmalm C; Matthews DA; Russell WC; Akusjärvi G
EMBO J; 1999 Feb; 18(4):1014-24. PubMed ID: 10022843
[TBL] [Abstract][Full Text] [Related]
8. HIV Rev-dependent binding of SF2/ASF to the Rev response element: possible role in Rev-mediated inhibition of HIV RNA splicing.
Powell DM; Amaral MC; Wu JY; Maniatis T; Greene WC
Proc Natl Acad Sci U S A; 1997 Feb; 94(3):973-8. PubMed ID: 9023367
[TBL] [Abstract][Full Text] [Related]
9. Exonic splicing enhancer-dependent selection of the bovine papillomavirus type 1 nucleotide 3225 3' splice site can be rescued in a cell lacking splicing factor ASF/SF2 through activation of the phosphatidylinositol 3-kinase/Akt pathway.
Liu X; Mayeda A; Tao M; Zheng ZM
J Virol; 2003 Feb; 77(3):2105-15. PubMed ID: 12525645
[TBL] [Abstract][Full Text] [Related]
10. The human splicing factors ASF/SF2 and SC35 possess distinct, functionally significant RNA binding specificities.
Tacke R; Manley JL
EMBO J; 1995 Jul; 14(14):3540-51. PubMed ID: 7543047
[TBL] [Abstract][Full Text] [Related]
11. Human splicing factor ASF/SF2 encodes for a repressor domain required for its inhibitory activity on pre-mRNA splicing.
Dauksaite V; Akusjärvi G
J Biol Chem; 2002 Apr; 277(15):12579-86. PubMed ID: 11801589
[TBL] [Abstract][Full Text] [Related]
12. Both phosphorylation and dephosphorylation of ASF/SF2 are required for pre-mRNA splicing in vitro.
Cao W; Jamison SF; Garcia-Blanco MA
RNA; 1997 Dec; 3(12):1456-67. PubMed ID: 9404896
[TBL] [Abstract][Full Text] [Related]
13. Regulation of SRp20 exon 4 splicing.
Jumaa H; Nielsen PJ
Biochim Biophys Acta; 2000 Nov; 1494(1-2):137-43. PubMed ID: 11072076
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of essential splicing factor ASF/SF2 blocks the temporal shift in adenovirus pre-mRNA splicing and reduces virus progeny formation.
Molin M; Akusjärvi G
J Virol; 2000 Oct; 74(19):9002-9. PubMed ID: 10982344
[TBL] [Abstract][Full Text] [Related]
15. A serine/arginine-rich domain in the human U1 70k protein is necessary and sufficient for ASF/SF2 binding.
Cao W; Garcia-Blanco MA
J Biol Chem; 1998 Aug; 273(32):20629-35. PubMed ID: 9685421
[TBL] [Abstract][Full Text] [Related]
16. The subcellular localization of SF2/ASF is regulated by direct interaction with SR protein kinases (SRPKs).
Koizumi J; Okamoto Y; Onogi H; Mayeda A; Krainer AR; Hagiwara M
J Biol Chem; 1999 Apr; 274(16):11125-31. PubMed ID: 10196197
[TBL] [Abstract][Full Text] [Related]
17. Treatment with IL-17 prolongs the half-life of chemokine CXCL1 mRNA via the adaptor TRAF5 and the splicing-regulatory factor SF2 (ASF).
Sun D; Novotny M; Bulek K; Liu C; Li X; Hamilton T
Nat Immunol; 2011 Aug; 12(9):853-60. PubMed ID: 21822258
[TBL] [Abstract][Full Text] [Related]
18. Regulated tissue-specific expression of antagonistic pre-mRNA splicing factors.
Hanamura A; Cáceres JF; Mayeda A; Franza BR; Krainer AR
RNA; 1998 Apr; 4(4):430-44. PubMed ID: 9630249
[TBL] [Abstract][Full Text] [Related]
19. Phosphorylation of the ASF/SF2 RS domain affects both protein-protein and protein-RNA interactions and is necessary for splicing.
Xiao SH; Manley JL
Genes Dev; 1997 Feb; 11(3):334-44. PubMed ID: 9030686
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylation-dephosphorylation differentially affects activities of splicing factor ASF/SF2.
Xiao SH; Manley JL
EMBO J; 1998 Nov; 17(21):6359-67. PubMed ID: 9799243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
